Literature DB >> 6170635

Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA.

R M Burger, J Peisach, S B Horwitz.   

Abstract

"Activated bleomycin" is an oxygenated iron drug complex which embodies the drug's DNA-cleaving activity. This activity is exercised on DNA, if present, but if DNA is absent, the drug itself is inactivated. Hyperfine interactions in the EPR spectra of activated bleomycin prepared with 57Fe(II) and 17O2 demonstrate the presence of iron as Fe(III) and of bound oxygen originating in dioxygen. Bleomycin can also be activated with Fe(III) and either H2O2 or ethyl hydroperoxide. These latter reactions do not produce a ferrous intermediate nor do they require O2. But O2 is required for the reaction of activated bleomycin with DNA to yield the malondialdehyde-like chromogens used to monitor DNA degradation. The attack on DNA is quantitatively concurrent with the decay of activated bleomycin, however generated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170635

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Catalytic mechanism of bleomycin N-acetyltransferase proposed on the basis of its crystal structure.

Authors:  Kosuke Oda; Yasuyuki Matoba; Masafumi Noda; Takanori Kumagai; Masanori Sugiyama
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

Review 2.  Structural biological study of self-resistance determinants in antibiotic-producing actinomycetes.

Authors:  Masanori Sugiyama
Journal:  J Antibiot (Tokyo)       Date:  2015-04-15       Impact factor: 2.649

3.  Determination of hypersensitivity to genotoxic agents among Escherichia coli single gene knockout mutants.

Authors:  Elinne Becket; Frank Chen; Cindy Tamae; Jeffrey H Miller
Journal:  DNA Repair (Amst)       Date:  2010-07-31

4.  Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycin.

Authors:  Blazej Rubis; Michal W Luczak; Casey Krawic; Anatoly Zhitkovich
Journal:  Free Radic Biol Med       Date:  2019-03-26       Impact factor: 7.376

5.  Crystal Structure of the Zorbamycin-Binding Protein ZbmA, the Primary Self-Resistance Element in Streptomyces flavoviridis ATCC21892.

Authors:  Jeffrey D Rudolf; Lance Bigelow; Changsoo Chang; Marianne E Cuff; Jeremy R Lohman; Chin-Yuan Chang; Ming Ma; Dong Yang; Shonda Clancy; Gyorgy Babnigg; Andrzej Joachimiak; George N Phillips; Ben Shen
Journal:  Biochemistry       Date:  2015-11-05       Impact factor: 3.162

6.  The metal bonding domain of the antitumor drug Fe(II)-bleomycin: a DFT investigation.

Authors:  Anna Karawajczyk; Francesco Buda
Journal:  J Biol Inorg Chem       Date:  2004-12-01       Impact factor: 3.358

7.  DNA structure influences sequence specific cleavage by bleomycin.

Authors:  K P Nightingale; K R Fox
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

8.  Fatty acid nitroalkenes inhibit the inflammatory response to bleomycin-mediated lung injury.

Authors:  Melissa L Wilkinson; Elena Abramova; Changjiang Guo; James G Gow; Alexa Murray; Adolf Koudelka; Veronika Cechova; Bruce A Freeman; Andrew J Gow
Journal:  Toxicol Appl Pharmacol       Date:  2020-09-12       Impact factor: 4.219

9.  Peroxo and oxo intermediates in mononuclear nonheme iron enzymes and related active sites.

Authors:  Edward I Solomon; Shaun D Wong; Lei V Liu; Andrea Decker; Marina S Chow
Journal:  Curr Opin Chem Biol       Date:  2009-03-09       Impact factor: 8.822

10.  Characterization of an Fe III-OOH species and its decomposition product in a bleomycin model system.

Authors:  Michael R Bukowski; Shourong Zhu; Kevin D Koehntop; William W Brennessel; Lawrence Que
Journal:  J Biol Inorg Chem       Date:  2003-10-15       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.